COAG SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000315066-26-002938
COAG filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 6, 2026. An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Hemab Therapeutics Holdings, Inc. (COAG). The stock moved +7.6% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Hemab Therapeutics Holdings, Inc. (COAG). The filing indicates a change in the holder's previously reported beneficial ownership.
Key details
How COAG stock reacted
Close before
$45.57
Nov 5, 2026
First close after
+7.57%
$49.02
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for COAG, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for COAG?
Click hereFrequently asked questions
What did COAG file with the SEC on Nov 6, 2026?
COAG filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing a passive ownership position in Hemab Therapeutics Holdings, Inc. (COAG). The filing indicates a change in the holder's previously reported beneficial ownership.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did COAG stock react to this filing?
COAG closed at $45.57 before the filing and $49.02 on Nov 6, 2026 (+7.57%).
Other COAG SEC filings
Get alerts when COAG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days